The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 999-1006, May 2008

The inflammatory effect of cardiopulmonary bypass on leukocyte extravasation in vivo

  • B.J. Evans, MRCS

      Affiliations

    • British Heart Foundation, the Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom
  • ,
  • D.O. Haskard, DM

      Affiliations

    • Cardiovascular Medicine Units, Eric Bywaters Centre, Imperial College Faculty of Medicine, Hammersmith Hospital, London, United Kingdom
  • ,
  • J.R. Finch, MRCS

      Affiliations

    • British Heart Foundation, the Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom
  • ,
  • I.R. Hambleton, PhD

      Affiliations

    • Edmund Cohen Laboratory for Vascular Research, Chronic Disease Research Centre, UWI, Bridgetown, Barbados
  • ,
  • R.C. Landis, PhD

      Affiliations

    • Edmund Cohen Laboratory for Vascular Research, Chronic Disease Research Centre, UWI, Bridgetown, Barbados
    • Corresponding Author InformationAddress for reprints: Dr. Clive Landis, Edmund Cohen Laboratory for Vascular Research, Chronic Disease Research Centre, UWI, Jemmotts Lane, Bridgetown BB 11115, Barbados
  • ,
  • K.M. Taylor, MD

      Affiliations

    • British Heart Foundation, the Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom

Received 16 March 2007; received in revised form 22 August 2007; accepted 30 August 2007.

Objective

Extravascular trafficking of leukocytes into organs is thought to play a major role in the pathophysiologic mechanisms of the inflammatory response to cardiopulmonary bypass, yet leukocyte extravasation is difficult to study clinically. Here we have tested the hypothesis that leukocyte emigration into skin blisters can provide a way to monitor the inflammatory effect of cardiopulmonary bypass that allows testing of anti-inflammatory interventions (exemplified by aprotinin).

Methods

Patients undergoing primary elective coronary artery bypass grafting (n = 14) were randomized into 2 equal groups to receive saline infusion during cardiopulmonary bypass (control group) or high-dose aprotinin. Experimental skin blisters (in duplicate) were induced on the forearm by means of topical application of the vesicant cantharidin, and blister fluid was sampled at 5 hours postoperatively. Inflammatory leukocyte subsets in blister fluid were analyzed by means of flow cytometry by using expression of CD11b and CD62L as a phenotypic marker of activation.

Results

In the control group of patients, cardiopulmonary bypass surgery triggered a 381% increase in leukocyte extravasation into the skin compared with reference blisters carried out before surgical intervention, with neutrophil (P = .014), monocyte (P = .014), and eosinophil (P = .009) levels all statistically significantly increased. In the aprotinin group there was no statistically significant increase during cardiopulmonary bypass surgery in any inflammatory leukocyte subset. The activation phenotype of extravascular leukocytes was not significantly altered between surgical groups.

Conclusions

This study introduces the cantharidin blister technique as a powerful new research tool for analyzing the inflammatory effect of cardiopulmonary bypass in vivo. It has provided detailed molecular insight into the extravascular leukocyte population during cardiopulmonary bypass. Although aprotinin blocked cardiopulmonary bypass–dependent extravasation of leukocytes, there was no change in their CD11b/CD62L activation status. The cantharidin skin test thus represents a novel research tool for evaluating future anti-inflammatory interventions in cardiothoracic surgery.

Abbreviations and Acronyms: BAL, bronchoalveolar lavage, CABG, coronary artery bypass grafting, CPB, cardiopulmonary bypass, ELISA, enzyme-linked immunosorbent assay, IL, interleukin, TNF, tumor necrosis factor

CTSNet Classification: 35

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by grants from the British Heart Foundation (D.O.H. and K.M.T) and the Hammersmith Hospitals Trustee's Research Committee (B.J.E. and R.C.L.).

 R. C. Landis reports lecture fees and Grant support from Bayer.

PII: S0022-5223(07)01868-5

doi:10.1016/j.jtcvs.2007.08.071

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 999-1006, May 2008